Infectious Pneumonia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-24
Clinical Trial Update: Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating Reparixin added to standard care to limit disease progression in patients with COVID-19 and other community-acqui…